Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four–week study
Fabrizio Cantini, Laura Niccoli, Maurizio Benucci, Daniela Chindamo, Carlotta Nannini, Ignazio Olivieri, Angela Padula, Carlo SalvaraniVolume:
55
Year:
2006
Language:
english
Pages:
5
DOI:
10.1002/art.22236
File:
PDF, 64 KB
english, 2006